Role of C-Peptide in Regulating Blood Flow in Diabetes
Author Information
Author(s): Forst T., Kunt T., Wilhelm B., Weber M. M., Pfützner A.
Primary Institution: Medical Department, Institute for Clinical Research and Development, Mainz, Germany
Hypothesis
C-peptide plays a significant role in regulating microvascular blood flow in type 1 diabetes.
Conclusion
C-peptide supplementation improves microvascular blood flow and endothelial function in type 1 diabetic patients.
Supporting Evidence
- C-peptide increases microvascular blood flow in type 1 diabetic patients.
- Supplementation of C-peptide improves endothelial function.
- Patients with residual C-peptide secretion have a lower risk of microvascular complications.
Takeaway
C-peptide helps blood flow in people with type 1 diabetes, making their blood vessels work better.
Methodology
The study reviewed various research findings on the effects of C-peptide on microvascular blood flow and endothelial function.
Limitations
The vascular effects of C-peptide were not confirmed in all tissues, indicating potential tissue-specific differences.
Participant Demographics
The study primarily focused on type 1 diabetic patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website